Addressing Barriers to Cancer Care for AIAN and NHPI Individuals Grant
Funding Amount
Up to US $250,000
Deadline
Rolling / Open
Grant Type
foundation
Overview
Addressing Barriers to Cancer Care for AIAN and NHPI Individuals Grant
Status: ACTIVE
Funder: Pfizer, Inc.
Amount: Up to US $250,000
Last Updated: April 16, 2025
Summary
The American Cancer Society and Pfizer are launching a grant initiative aimed at enhancing cancer care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) populations. This program encourages projects that address various barriers to treatment, emphasizing cultural and geographic factors. Proposals should adopt evidence-based methodologies and focus on sustainable, scalable solutions. Priority will be given to projects that demonstrate a clear impact on patient care and improve treatment outcomes for these communities.Overview
Background The American Cancer Society (ACS) and Pfizer are collaborating to offer a new competitive grant opportunity focused on improving cancer care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) individuals in cancer treatment. This Request for Proposals (RFP) is not specific to one cancer type. Proposals should identify and address barriers impacting the population of focus regardless of cancer type. To accelerate the timeline for this RFP, Letters of Intent are not requested. Full proposals are required for all submissions. Area of Interest The intent of this grants program is to support quality improvement projects that reduce cancer treatment disparities and strengthen collaborations to improve cancer care for AIAN and NHPI individuals facing cancer. It is expected that projects are built on the foundation of an evidencebased approach, and the proposed evaluation plan will follow generally accepted scientific principles. During review, the intended outcome(s) of the project will be given careful consideration and projects with the maximum likelihood to directly impact patient care for AIAN and/or NHPI oncology patients across multiple cancer types and those that are sustainable post quality improvement project, scalable or replicable will be given highest priority. The intent of the collaboration is to support proposals focused on aspects related to cancer treatment. Proposals are asked to address cultural and geographic barriers to the delivery of standard of care (SOC) treatment. Additional barriers may also be addressed. Example project proposal topics may include: Delayed Diagnosis/late presentationTreatment selectionAdherence to SOCBias in treatment choiceShared decision makingCare delivery/adherenceAccess to care (e.g., social support, navigation)Socioeconomic barriersTreatment outcomesClinical trials participationPalliative CareSurvivorship supportEligibility
We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.Focus Areas & Funding Uses
Fields of Work
cancernative-americanshealth-disparities
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Foundation
Alaska Run for Women Grants
Amount
Varies
Deadline
August 15, 2026
Annual
Foundation
SBIR Innovative Molecular Analysis Technology (IMAT) Development for Cancer Research and Clinical Care
Amount
Varies
Deadline
Rolling / Open
Foundation
ACC Mini Grants - Cancer Prevention
Amount
$3,500 - $5,500
Deadline
Rolling / Open
Annual
Foundation
ACP Tobacco Prevention Grants (Mini Grants)
Amount
$3,500 - $5,500
Deadline
Rolling / Open
Annual
Foundation
ACP Cancer Transportation Grants
Amount
$3,500
Deadline
Rolling / Open
Annual
Foundation
Advanced Clinical Research Award - Breast Cancer Research Grant
Conquer Cancer Foundation
Amount
Up to US $450,000
Deadline
Rolling / Open
Ready to apply for Addressing Barriers to Cancer Care for AIAN and NHPI Individuals Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.